JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Testa, L.
Right arrow Articles by Agostoni, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Testa, L.
Right arrow Articles by Agostoni, P.

J Thorac Cardiovasc Surg 2007;134:816-817
© 2007 The American Association for Thoracic Surgery

Letter to the Editor

Letters to the Editor

Luca Testa, MD, PhDa, William van Gaal, MDa, Giuseppe G. Biondi-Zoccai, MDb, Antonio Abbate, MDc, Ravinay Bhindi, MD, PhDd, Pierfrancesco Agostonie

a Institute of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom
b Division of Cardiology, University of Turin, Turin, Italy
c Department of Medicine, Virginia Commonwealth University, Richmond, Va
d Institute of Cardiology, Catholic University, Rome, Italy
e Antwerp Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium

The first 20% of the full text of this article appears below.

To the Editor:

We carefully read the interesting article by Bainbridge and colleagues1Go comparing, by means of a meta-analytic approach, the available evidence on off-pump coronary artery bypass surgery (OPCABG) with percutaneous coronary intervention (PCI). Six trials involving 989 patients were included. All but 1 trial included only patients with isolated proximal left anterior descending disease. Only 1 trial used paclitaxel or sirolimus-eluting stents. The authors concluded that OPCABG is associated with better short-term and midterm clinical outcomes but also with an increased length of hospital stay.

The authors correctly suggested projecting the results to a population larger than that of the included studies. For example, for every 1000 low-risk patients undergoing OPCABG, there will be approximately 105 fewer patients with recurrent angina, 143 fewer patients with target vessel failure, and 125 fewer patients with major adverse . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.